h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
CHOPi003-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
CHOPi003-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
CHOPi003-A (RRID:CVCL_UL70)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
27th November 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
The Children's Hospital of Philadelphia (CHOP)
External Databases
Cellosaurus
CVCL_UL70
Wikidata
Q93453046
General Information
Publications
Maguire JA et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem cell research. 2019 Jan;34:101361.
Egorova PA et al. Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2019 Oct;16(4):1050-1073.
Naphade S et al. Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2019 Oct;16(4):979-998.
Slanzi A et al. In vitro Models of Neurodegenerative Diseases. Frontiers in cell and developmental biology. 2020;8:328.
Egorova P. A. et al. New Approaches in Studies of the Molecular Pathogenesis of Type 2 Spinocerebellar Ataxia. Neuroscience and Behavioral Physiology. 2020-09-00.
Leavens KF et al. Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem cell research. 2020 Dec 8;50:102112.
Appelt PA et al. Effect of stem cell treatment on functional recovery of spinocerebellar ataxia: systematic review and meta-analysis. Cerebellum & ataxias. 2021 Feb 25;8(1):8.
Correia JS et al. Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update. Neural regeneration research. 2023 Jun;18(6):1203-1212.
Takasaki K et al. Generation of 2 isogenic clones from a patient with Trisomy 21 and a GATA1 mutation. Stem cell research. 2023 Jun;69:103098.
Hashmi SK et al. Generation of CHOPe003-A ESC line to study an ACTG2 variant affecting smooth muscle development and function. Stem cell research. 2023 Sep;71:103186.
Hashmi SK et al. Generation of CHOPi012-A iPSC line from a patient with visceral myopathy-related chronic intestinal pseudo-obstruction. Stem cell research. 2023 Sep;71:103176.
Takasaki K et al. Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a GATA1 mutation. Stem cell research. 2023 Oct;72:103198.
Pham Vi et al. A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency. Molecular Genetics and Metabolism. 2023-12-00.
Raghunathan N et al. A comprehensive review of iPS cell line-based disease modelling of the polyglutamine spinocerebellar ataxias 2 and 3: a focus on the research outcomes. Ann Med Surg (Lond). 2024-03-19.
Leavens Karla F. et al. Generation of a fluorescent mNeonGreen insulin reporter line in the H1 (WA01) hESC background. Stem Cell Research. 2024-12-00.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.